NEW HAVEN, Conn. (WTNH) – A Yale associate professor has developed a new treatment for cancer that is entering clinical trials.
According to Yale University officials, Associate Professor Tarek Fahmy has developed a new immunotherapy drug delivery system that can carry multiple drugs inside a tiny particle. The new delivery system is getting ready to start its first phase of clinical trials for a possibly new treatment for cancer.
“It creates a new solution that could potentially deal a significant blow to cancer and even autoimmune disease in future applications,” said Fahmy, who teaches biomedical engineering and immunobiology.
According to officials, the delivery system is a nanogel that can be used for multiple combinations of drugs for many different cancers and some immune disorders. The platform is designed to deliver multiple drugs with different chemical properties. A single particle can carry hundreds of drug molecules that concentrate in the tumor, increasing the efficiency of the drug combination while decreasing its toxicity.
“It’s about leveraging the biology of the system, not fighting it,” added Brian Horsburgh, CEO of Immunova and Modulate. “You want to wake up the immune system and harness that.”